The pharmaceutical industry works within rigid regulations that govern its behaviour in both the development and promotion of its medicines and understands all-too-well the financial and reputational penalties of getting it wrong.
Award-winning global healthcare communications group HAVAS LYNX have announced the creation of a new medical education and scientific exchange agency –HAVAS LYNX MEDICAL.